ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 255

Healing Time and Blood Perfusion By Laser Speckle Contrast Analysis in Patients with Systemic Sclerosis and Digital Ulcers

Simone Barsotti1,2, Anna d'Ascanio1, Valentina Venturini3, Laura Amanzi4, Silvia Bilia5, Marta Mosca1 and Alessandra Della Rossa6, 1Rheumatology Unit, University of Pisa, Pisa, Italy, 2Department of Medical Biotechnologies, University of Siena, Siena, Italy, 3Pisa University Hospital, Rheumatology unit, Pisa, Italy, 4Pisa University Hospital, Rheumatology Unit, Pisa, Italy, 5Univerisity of Pisa, Rheumatology Unit, Pisa, Italy, 6University of Pisa, Rheumatology Unit, Pisa, Italy

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: systemic sclerosis and wounds

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 5, 2017

Title: Imaging of Rheumatic Diseases Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

Digital ulcers (DUs) are a major burden in patients with systemic sclerosis (SSc). Laser speckle contrast analysis (LASCA) is a novel technique that can analyse blood perfusion (BP) in the fingers and in DU areas. The objective of the present study was to evaluate BP in patients with SSc and DUs and correlate these values with the treatments and healing time.

Methods:

From February 2016 to March 2017, 23 consecutive Ssc patients presenting with DU at fingertips were enrolled: M:F=2:21; 15 lcSSc and 8 dcSSc; mean age 56±15.8 years. BP was assessed by LASCA in fingers affected by DUs, unaffected fingers, DU area, peri-ulcer area and the same area of unaffected fingers. DUs were defined infected if local signs of infection were present (swelling, severe pain, erythema, discharge). The treatment with major vasoactive drugs (iloprost, bosentan, sildenafil), the latency between the appearance of DU and first evaluation, and the time to DU healing under standard local treatment were collected.

Results:

BP was higher in peri-ulcer area with respect to the DUs area ( 84.1±21.0 vs 60.3±15.1 p<0.001), and no differences were observed between DUs area and similar area of unaffected fingers.

In patients without infection (n=17), healing time was negatively associated both to DUs BP (r=-0.618 p=0.011) and peri-ulcer BP (r=-0.488 p=0.011). The latency between appearance of DUs and first evaluation in our centre was also negatively correlated to mean healing time (r=0.36 p=0.036).

Patients with infection (n=6) presented a higher ulcer BP compared to non-infected pts (198.0±112.2 vs 103.3±66 p=0.023) and DUs needed a longer healing time (mean 130 vs 100 days).

The treatment with bosentan and iloprost was associated with higher BP in the unaffected fingers (respectively p=0.002 and p=0.001) but no BP changes at DU area or at fingers with DUs were observed. Sildenafil was not associated with significant differences in blood perfusion.

Conclusion:

Our study suggests a potential usefulness of LASCA analysis of BP in the assessment of DUs in SSc patients. Although all DUs are ischaemic in nature (blood flow is lower than in unaffected area and periulcer area), BP values could help in identifying difficult to heal lesions, either due to a markedly reduced perfusion (low BP) or to the presence of an infection (higher than expected BP).

Additional data are needed to better define the role of BP as a guide to treatment, ulcer management and prevention in routine clinical practice.


Disclosure: S. Barsotti, None; A. d'Ascanio, None; V. Venturini, None; L. Amanzi, None; S. Bilia, None; M. Mosca, None; A. Della Rossa, None.

To cite this abstract in AMA style:

Barsotti S, d'Ascanio A, Venturini V, Amanzi L, Bilia S, Mosca M, Della Rossa A. Healing Time and Blood Perfusion By Laser Speckle Contrast Analysis in Patients with Systemic Sclerosis and Digital Ulcers [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/healing-time-and-blood-perfusion-by-laser-speckle-contrast-analysis-in-patients-with-systemic-sclerosis-and-digital-ulcers/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/healing-time-and-blood-perfusion-by-laser-speckle-contrast-analysis-in-patients-with-systemic-sclerosis-and-digital-ulcers/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology